vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $18.6M, roughly 1.2× Zeo Energy Corp.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -0.4%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -4.0%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

ADCT vs ZEO — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.2× larger
ADCT
$23.1M
$18.6M
ZEO
Growing faster (revenue YoY)
ADCT
ADCT
+36.8% gap
ADCT
36.4%
-0.4%
ZEO
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-4.0%
ZEO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
ZEO
ZEO
Revenue
$23.1M
$18.6M
Net Profit
$-2.0M
Gross Margin
Operating Margin
-77.7%
-11.8%
Net Margin
-10.8%
Revenue YoY
36.4%
-0.4%
Net Profit YoY
-360.9%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
ZEO
ZEO
Q4 25
$23.1M
$18.6M
Q3 25
$15.8M
$23.9M
Q2 25
$18.1M
$18.1M
Q1 25
$17.4M
$8.8M
Q4 24
$16.9M
$18.6M
Q3 24
$18.0M
$19.7M
Q2 24
$17.0M
$14.8M
Q1 24
$17.8M
$20.1M
Net Profit
ADCT
ADCT
ZEO
ZEO
Q4 25
$-2.0M
Q3 25
$-41.0M
$-3.2M
Q2 25
$-56.6M
$-2.4M
Q1 25
$-38.6M
$-6.4M
Q4 24
$-435.3K
Q3 24
$-44.0M
$-424.3K
Q2 24
$-36.5M
$-277.8K
Q1 24
$-46.6M
$-1.5M
Gross Margin
ADCT
ADCT
ZEO
ZEO
Q4 25
Q3 25
57.9%
Q2 25
59.8%
Q1 25
99.3%
Q4 24
Q3 24
50.2%
Q2 24
52.3%
Q1 24
Operating Margin
ADCT
ADCT
ZEO
ZEO
Q4 25
-77.7%
-11.8%
Q3 25
-196.6%
-8.3%
Q2 25
-244.1%
-15.8%
Q1 25
-163.5%
-153.8%
Q4 24
-191.8%
-6.0%
Q3 24
-197.4%
-15.2%
Q2 24
-170.5%
-18.0%
Q1 24
-188.3%
-20.1%
Net Margin
ADCT
ADCT
ZEO
ZEO
Q4 25
-10.8%
Q3 25
-260.1%
-13.5%
Q2 25
-313.2%
-13.3%
Q1 25
-221.8%
-72.4%
Q4 24
-2.3%
Q3 24
-244.1%
-2.2%
Q2 24
-214.6%
-1.9%
Q1 24
-261.1%
-7.6%
EPS (diluted)
ADCT
ADCT
ZEO
ZEO
Q4 25
$0.04
Q3 25
$-0.30
Q2 25
$-0.50
Q1 25
$-0.36
$-0.48
Q4 24
$-0.26
$1.11
Q3 24
$-0.42
$-0.08
Q2 24
$-0.38
$0.03
Q1 24
$-0.56
$-1.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
ZEO
ZEO
Cash + ST InvestmentsLiquidity on hand
$261.3M
$6.1M
Total DebtLower is stronger
$79.1K
Stockholders' EquityBook value
$-185.8M
$5.3M
Total Assets
$323.1M
$56.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
ZEO
ZEO
Q4 25
$261.3M
$6.1M
Q3 25
$234.7M
$3.9M
Q2 25
$264.6M
$68.7K
Q1 25
$194.7M
$2.9M
Q4 24
$250.9M
$5.6M
Q3 24
$274.3M
$4.3M
Q2 24
$300.1M
$5.3M
Q1 24
$234.3M
Total Debt
ADCT
ADCT
ZEO
ZEO
Q4 25
$79.1K
Q3 25
$84.6K
Q2 25
$642.8K
Q1 25
$715.4K
Q4 24
$787.7K
Q3 24
$858.6K
Q2 24
$1.6M
Q1 24
$748.8K
Stockholders' Equity
ADCT
ADCT
ZEO
ZEO
Q4 25
$-185.8M
$5.3M
Q3 25
$-238.2M
$-1.7M
Q2 25
$-199.2M
$-59.4M
Q1 25
$-238.2M
$-23.1M
Q4 24
$-202.6M
$-88.9M
Q3 24
$-171.9M
$-39.3M
Q2 24
$-131.7M
$-53.0M
Q1 24
$-194.4M
$-173.0M
Total Assets
ADCT
ADCT
ZEO
ZEO
Q4 25
$323.1M
$56.9M
Q3 25
$289.8M
$58.5M
Q2 25
$321.6M
$46.2M
Q1 25
$272.5M
$47.4M
Q4 24
$322.0M
$61.0M
Q3 24
$349.1M
$47.1M
Q2 24
$371.8M
$49.1M
Q1 24
$308.0M
$50.1M
Debt / Equity
ADCT
ADCT
ZEO
ZEO
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
ZEO
ZEO
Operating Cash FlowLast quarter
$-31.1M
$2.4M
Free Cash FlowOCF − Capex
$2.3M
FCF MarginFCF / Revenue
12.2%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
ZEO
ZEO
Q4 25
$-31.1M
$2.4M
Q3 25
$-29.6M
$-6.6M
Q2 25
$-24.1M
$-2.3M
Q1 25
$-56.3M
$-2.3M
Q4 24
$-21.9M
$3.5M
Q3 24
$-25.0M
$162.2K
Q2 24
$-32.8M
$-2.2M
Q1 24
$-44.1M
$-10.2M
Free Cash Flow
ADCT
ADCT
ZEO
ZEO
Q4 25
$2.3M
Q3 25
$-6.8M
Q2 25
$-2.7M
Q1 25
$-56.6M
$-2.6M
Q4 24
$-21.9M
$3.4M
Q3 24
$-25.3M
$116.5K
Q2 24
$-32.9M
$-2.3M
Q1 24
$-44.6M
$-10.4M
FCF Margin
ADCT
ADCT
ZEO
ZEO
Q4 25
12.2%
Q3 25
-28.6%
Q2 25
-15.0%
Q1 25
-325.2%
-30.0%
Q4 24
-129.8%
18.2%
Q3 24
-140.2%
0.6%
Q2 24
-193.0%
-15.6%
Q1 24
-250.0%
-51.5%
Capex Intensity
ADCT
ADCT
ZEO
ZEO
Q4 25
0.0%
0.9%
Q3 25
0.0%
1.0%
Q2 25
0.0%
2.4%
Q1 25
1.5%
4.2%
Q4 24
0.5%
0.5%
Q3 24
1.2%
0.2%
Q2 24
0.2%
0.7%
Q1 24
3.0%
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

ZEO
ZEO

Nonrelated Party$18.1M98%
Related Party$432.1K2%

Related Comparisons